taurine has been researched along with Amyloid Deposits in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Taurine is an abundant aminoacid present in brain." | 1.34 | Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-beta-peptide aggregation. ( Avila, J; Hernández, F; Moreno, FJ; Santa-María, I, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meng, F | 1 |
| Raleigh, DP | 1 |
| Aisen, PS | 1 |
| Saumier, D | 1 |
| Briand, R | 1 |
| Laurin, J | 1 |
| Gervais, F | 1 |
| Tremblay, P | 1 |
| Garceau, D | 1 |
| Santa-María, I | 1 |
| Hernández, F | 1 |
| Moreno, FJ | 1 |
| Avila, J | 1 |
1 trial available for taurine and Amyloid Deposits
| Article | Year |
|---|---|
A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Diarrhea; Dose-Response Re | 2006 |
2 other studies available for taurine and Amyloid Deposits
| Article | Year |
|---|---|
Inhibition of glycosaminoglycan-mediated amyloid formation by islet amyloid polypeptide and proIAPP processing intermediates.
Topics: Amyloid; Benzenesulfonates; Diabetes Mellitus, Type 2; Heparitin Sulfate; Humans; Insulin-Secreting | 2011 |
Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-beta-peptide aggregation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Humans; Molecular Structure; Neurofibrillary Tangles; Plaq | 2007 |